HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 11.26
Day range
kr 9.59 - kr 11.58
Year range
kr 2.62 - kr 17.98
Market cap
336.90M SEK
Avg Volume
359.49K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.61M | -78.02% |
Net income | -10.60M | 80.14% |
Net profit margin | — | — |
Earnings per share | -0.31 | 79.74% |
EBITDA | -11.60M | 78.04% |
Effective tax rate | 1.03% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.86M | -85.39% |
Total assets | 87.07M | -60.16% |
Total liabilities | 12.74M | -66.21% |
Total equity | 74.33M | — |
Shares outstanding | 33.76M | — |
Price to book | 5.12 | — |
Return on assets | -30.02% | — |
Return on capital | -36.02% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -10.60M | 80.14% |
Cash from operations | -15.93M | 44.53% |
Cash from investing | 0.00 | — |
Cash from financing | -220.00K | 7.95% |
Net change in cash | -17.14M | 43.36% |
Free cash flow | -13.19M | 27.84% |
About
Founded
1999
Website
Employees
13